Patients transplanted between January 2011 and February 2013 were randomly divided into 3 groups to receive routine anti-rejection medication only ( n = 32 ) , NAC plus routine immunosuppressive regimen ( NAC group ; n = 33 ) , and NAC and vitamin C plus routine regimen ( NAC and vitamin C group ; n = 19 ) .